Project Grant R21NS142744

Award Date 5/15/25
Completion Date 4/30/27
Dollars Obligated $429K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $429,000 in funding to Thomas Jefferson University (doing business as Sidney Kimmel Medical College) for a 2-year research project. The objective is to further understand the mechanism underlying the role of androgen receptor serine 16 phosphorylation in the pathogenesis of...
This federal Project Grant award of $438,365 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will fund research to investigate the role of the CD38 protein in Spinal and Bulbar Muscular Atrophy (SBMA). The research will use stem cell technology and CRISPR-corrected isogenic controls to study metabolic alterations in SBMA patient-derived cells differentiated into...
This $429,000 award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to investigate therapeutic strategies for rescuing metabolic deficiencies in spinal and bulbar muscular atrophy (SBMA). The project will leverage two SBMA mouse models to evaluate whether systemic administration of nicotinamide mononucleotide (NMN) can bypass deficiencies in the muscle...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $151,600 project grant under CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders to the Philadelphia College of Osteopathic Medicine (PCOM) to generate and characterize a Cre-Lox regulated transgenic zebrafish model of spinal and bulbar muscular atrophy (SBMA). This rare neuromuscular disorder, also known as Kennedy's Disease, affects men and currently has no cure or therapy....
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $459,250 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for a 2-year period from July 2024 to June 2026. The project aims to develop an isogenic human neural stem cell model to isolate and characterize extracellular vesicles, and then use these vesicles to...
This $565,054 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research on neuroinflammation and motor neuron loss in Spinal Muscular Atrophy (SMA) at the Medical College of Wisconsin, Inc. (MCW). The key objectives are to elucidate the molecular mechanisms causing astrocyte dysfunction and its downstream impacts on microglial...
This Project Grant award of $697,907.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The funding supports research at Thomas Jefferson University's Sidney Kimmel Medical College to investigate the involvement of the C-JUN/transposable element (TE)/cGAS/STING pathway in C9ORF72-associated amyotrophic lateral sclerosis and frontotemporal...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) is providing $390,000.00 to Thomas Jefferson University (doing business as Sidney Kimmel Medical College) to elucidate the mechanisms underlying DNA double-strand break repair. The research aims to understand how the multi-enzyme complex that mediates DNA resection - a key step in DNA repair pathway choice - assembles and is...
This federal Project Grant award for $2,307,075.00, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports innovative research aimed at defining novel mechanisms of neurodegenerative diseases and devising potential therapeutic strategies. The primary recipient, The Leland Stanford Junior University, will conduct genome-wide modifier screens in human...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders will fund research to examine the role of a specific huntingtin (HTT) isoform, HTT1A, in the progression of Huntington's disease. The $100,060 grant awarded to the University of Massachusetts Medical School will investigate how HTT1A expression and its interaction with mutant HTT protein affect the...

This $429,000 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research on somatic instability of CAG repeats in spinal and bulbar muscular atrophy (SBMA). The research aims to evaluate the tissue selectivity and temporal relationship of somatic instability in aging SBMA mouse models and human SBMA muscle biopsies, and investigate the role of somatic expansion in the disease process. The ultimate goal is to develop a mechanistic understanding of SBMA pathogenesis and identify new therapeutic directions for this neurodegenerative disease. The award recipient is Thomas Jefferson University, doing business as Sidney Kimmel Medical College, a private non-profit academic medical center in Philadelphia, Pennsylvania. The project period spans from May 2025 to April 2027.

Generated 6/17/25, 2:15 AM